Reuters logo
BRIEF-Morphosys says to receive milestone payments from Janssen
September 21, 2017 / 5:33 AM / 3 months ago

BRIEF-Morphosys says to receive milestone payments from Janssen

Sept 21 (Reuters) - Morphosys AG

* Says announces that its licensee Janssen has initiated two phase 3 studies with TremfyaTM (guselkumab) in psoriatic arthritis

* Says will receive a milestone payment from Janssen in connection with start of phase 3 development in PSA

* Says financial details were not disclosed Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below